Heron Therapeutics (HRTX) Current Leases (2019 - 2025)
Historic Current Leases for Heron Therapeutics (HRTX) over the last 7 years, with Q3 2025 value amounting to $780000.0.
- Heron Therapeutics' Current Leases fell 7599.26% to $780000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $780000.0, marking a year-over-year decrease of 7599.26%. This contributed to the annual value of $3.0 million for FY2024, which is 123.58% down from last year.
- Per Heron Therapeutics' latest filing, its Current Leases stood at $780000.0 for Q3 2025, which was down 7599.26% from $1.5 million recorded in Q2 2025.
- Over the past 5 years, Heron Therapeutics' Current Leases peaked at $3.3 million during Q3 2021, and registered a low of $780000.0 during Q3 2025.
- Its 5-year average for Current Leases is $2.7 million, with a median of $2.8 million in 2023.
- Per our database at Business Quant, Heron Therapeutics' Current Leases skyrocketed by 2379.84% in 2024 and then crashed by 7599.26% in 2025.
- Quarter analysis of 5 years shows Heron Therapeutics' Current Leases stood at $2.4 million in 2021, then increased by 11.46% to $2.7 million in 2022, then rose by 14.14% to $3.1 million in 2023, then dropped by 1.24% to $3.0 million in 2024, then tumbled by 74.32% to $780000.0 in 2025.
- Its last three reported values are $780000.0 in Q3 2025, $1.5 million for Q2 2025, and $2.3 million during Q1 2025.